Together Against Overdose: community developed technology to encourage drug checking, distribution of harm reduction supplies, and linkage to services
Project Number1R61DA059035-01A1
Former Number1R61DA059035-01
Contact PI/Project LeaderARONSON, IAN DAVID
Awardee OrganizationNDRI-USA, INC.
Description
Abstract Text
Project Summary/Abstract
For more than 20 years, nationwide overdose death rates have set new records almost every year, and
increases continue. Current deaths are largely due to adulterants in the illicit drug supply, including fentanyl,
xylazine, and benzodiazepines. The unpredictable nature of adulterated drugs has created a new set of overdose
risks for people who use drugs. This includes people who have used heroin for many years as well as people
who use stimulants and previously faced little, if any, risk of opioid overdose. Although available drug checking
tools can help people determine the presence of dangerous adulterants prior to consumption, they may not be
used by those most at risk.
We, therefore, propose to build upon longstanding community partnerships and our team’s extensive
experience developing technology-based interventions for substance using populations in community settings,
to create new materials in English and Spanish designed to: increase behaviors that protect against overdose
(including drug checking), and facilitate linkage to harm reduction services available nearby. We also plan to
increase overdose related health literacy and to encourage initiation of medications for opioid use disorder.
Over the course of multiple NIH-funded studies our team has developed a highly iterative, participatory
methodology to understand barriers to enacting positive health behaviors among specific populations, and to
learn how these can be addressed using technology-based intervention content. The first step in our
methodology is to conduct a series of interviews to examine, in this case, why people who use drugs do not
engage in overdose protective behaviors, such as drug checking. We will then develop storyboards (paper
representations of onscreen content) to address identified barriers, and then elicit participant response. After
revising our content accordingly, we will then draft intervention content including short videos and still frame
images paired with text in the style of a graphic novel or comic book. We will then evaluate this content through
a third wave of interviews with a new set of participants. During this process, we will also empanel a stakeholder
advisory board of current substance users, care providers, and prospective payers who we consult at each step
of the design, development, and evaluation of our work.
After finalizing our intervention we will recruit a new sample of people who use drugs (n=800) via venue
based sampling and chain referral (waves of participants recruit others, who in turn recruit additional participants)
for a randomized controlled trial examining whether our intervention materials more effectively encourage
protective behaviors compared to a treatment as usual control condition. Exploratory analyses will examine
intervention effectiveness by participants’ behavioral characteristics (type of substances used, method of
administration) and demographics. If shown successful, our sustainable, low-threshold intervention design can
be readily scaled and adapted for substance using populations across the United States.
Public Health Relevance Statement
Project Narrative
To address the ongoing nationwide crisis of overdose deaths we propose to develop technology that encourages
people who use drugs to protect themselves and the people around them, and that facilitates linkage to available
harm reduction services. We will collaborate with a network of community members with whom we have
developed strong relationships during prior research projects and will employ a highly participatory, iterative
approach to developing intervention content in English and Spanish. Our proposed intervention is designed to
be readily scalable for sustainable use in urban settings nationwide, future iterations can be developed for rural
populations.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdoptionBehaviorBehavioralBenzodiazepinesBooksCentral Nervous SystemCessation of lifeCharacteristicsCitiesCollaborationsCommunitiesCommunity NetworksConsolidated Framework for Implementation ResearchConsultConsumptionControl GroupsDangerousnessDataData CollectionData ReportingDeath RateDependenceDevelopmentDrug AdulterationsDrug MonitoringDrug UtilizationDrug usageDrug userEffectiveness of InterventionsEnsureEquityEvaluationExposure toFeedbackFentanylFundingFutureGenderHarm ReductionHealth behaviorHeroinIllicit DrugsImageInterventionInterviewLanguageLeadershipLearningLifeLocationMeasuresMethodologyMethodsMorphineNatureNeedle-Exchange ProgramsNew York CityOpioidOutcomeOverdoseOverdose reversalPainPaperParticipantPatient RecruitmentsPersonsPharmaceutical PreparationsPharmacologic SubstancePopulationPre-Post TestsProcessRaceRandomizedRandomized, Controlled TrialsRecordsReportingResearchResearch Project GrantsRiskRisk BehaviorsRisk ReductionRural PopulationSamplingSeriesServicesSpanish/EnglishStandardizationStimulantTablet ComputerTabletsTechniquesTechnologyTestingTextText MessagingTimeUnconscious StateUnited StatesUnited States National Institutes of HealthVentilatory DepressionWaste ProductsWithdrawal SymptomWorkXylazinecare providerscommunity partnershipcommunity settingdemographicsdesigndrug testingexperiencefollow up assessmentfollow-upgroup interventionhealth literacyheroin usemedication for opioid use disordermembernovelopioid overdoseopioid useroverdose deathoverdose preventionoverdose riskpeerpersonalized interventionpillprimary outcomeprospectiveprotective behaviorrecruitresponsescale upscreeningsecondary outcomeservice providersskin ulcersocial stigmastimulant usesubstance usesubstance usersynthetic opioidtailored messagingtechnology interventiontest striptherapy designtooltreatment as usualtreatment groupurban setting
No Sub Projects information available for 1R61DA059035-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R61DA059035-01A1
Patents
No Patents information available for 1R61DA059035-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R61DA059035-01A1
Clinical Studies
No Clinical Studies information available for 1R61DA059035-01A1
News and More
Related News Releases
No news release information available for 1R61DA059035-01A1
History
No Historical information available for 1R61DA059035-01A1
Similar Projects
No Similar Projects information available for 1R61DA059035-01A1